All Stories

The power of patient communities: How patient communiti...

Patient communities on social are more than just support networks; they are livi...

Cosette sets sights on women's healthcare stardom with ...

The combined company will offer a diverse portfolio of women's healthcare pills ...

Once valued at $10B, bluebird bio sold to private equit...

Private equity firms Carlyle and SK Capital have agreed to pay $29 million to ac...

Novo Nordisk's semaglutide shortage officially conclude...

The FDA has officially declared an end to the supply squeeze on Novo Nordisk’s G...

Pfizer discontinues hemophilia treatment Beqvez, emptyi...

Pfizer is pulling further away from the gene therapy field with its decision to ...

PMCPA brings the buzzkill to LinkedIn celebration, layi...

The PMCPA has turned party pooper, coming down on GSK after learning that a U.K....

Regulatory tracker: Gilead's seladelpar nabs EU approva...

In this tracker, Fierce Pharma is recording the regulatory progress of in-market...

Fierce Pharma Asia—Novo Nordisk's fraud accusation; Ast...

Novo Nordisk alleges Singaporean biotech KBP Biosciences made misleading stateme...

A week after RFK Jr.'s confirmation, HHS postpones vacc...

Less than a week after newly confirmed HHS secretary Robert F. Kennedy Jr. quest...

Merck KGaA's EMD Serono taps Selma Blair to join long-r...

No cruel intentions here: Merck KGaA’s U.S. pharma arm has recruited actor Selma...

Canada locks down an initial 500K doses of GSK's bird f...

The Public Health Agency of Canada has leveraged an existing deal with GSK to lo...

Merck KGaA’s EMD Serono taps Selma Blair to join long-r...

No cruel intentions here: Merck KGaA’s U.S. pharma arm has recruited actor Selma...

Challenging powerhouse Pfizer, BridgeBio's launch of At...

BridgeBio reported that 1,028 unique prescriptions have been written by 516 diff...

Merck, plaintiff agree to hit the brakes on Gardasil tr...

Attorneys on the plaintiff's side, who are arguing that the vaccine caused injur...

CDC’s ‘Wild to Mild’ flu vaccine campaign muzzled amid ...

A popular awareness campaign now in its second year that encouraged people to ge...

Regulatory tracker: BMS' Breyanzi wins NICE backing in ...

In this tracker, Fierce Pharma is recording the regulatory progress of in-market...

FDA hits pair of Indian API makers with warning letters...

Jagsonpal Pharmaceuticals and Tyche Industries, both makers of APIs based in Ind...

AstraZeneca pays $160M for FibroGen's China unit, regio...

AstraZeneca is paying $160 million for FibroGen’s Chinese business, giving the U...

Genentech, Novartis join forces to raise awareness of f...

Genentech and Novartis have teamed up with FARE to enhance the safety of childre...

AstraZeneca pays $160M for Fibrogen's China unit, regio...

AstraZeneca is paying $160 million for Fibrogen’s Chinese business, giving the U...

PhRMA leaders prepare to meet with Trump as new chair A...

Ahead of a meeting with President Donald Trump, trade group the Pharmaceutical R...

Bristol Myers Squibb notches overall survival win with ...

Bristol Myers Squibb has bolstered its case for Opdivo to be used as a preoperat...

Ionis marks 'milestone event' of Tryngolza launch with ...

To support the launch of Tryngolza, which is approved to treat adults with famil...

Ionis marks ‘milestone event’ of Tryngolza launch with ...

To support the launch of Tryngolza, which is approved to treat adults with famil...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.